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Background: The purpose of this study was to determine the prevalence of individuals who 
experienced exercise-induced adverse cardiometabolic response (ACR), following an evidence-
based, individualized, community exercise program.
Methods: Prevalence of ACR was retrospectively analyzed in 332 adults (190 women, 142 men) 
before and after a 14-week supervised community exercise program. ACR included an exercise 
training-induced increase in systolic blood pressure of $10 mmHg, increase in plasma triglycer-
ides (TG) of .37.0 mg/dL ($0.42 mmol/L), or decrease in high-density lipoprotein cholesterol 
(HDL-C) of .4.0 mg/dL (0.12 mmol/L). A second category of ACR was also defined – this 
was ACR that resulted in a metabolic syndrome component (ACR-risk) as a consequence of 
the adverse response.
Results: According to the above criteria, prevalence of ACR between baseline and post-pro-
gram was systolic blood pressure (6.0%), TG (3.6%), and HDL-C (5.1%). The prevalence of 
ACR-risk was elevated TG (3.2%), impaired fasting blood glucose (2.7%), low HDL-C (2.2%), 
elevated waist circumference (1.3%), and elevated blood pressure (0.6%).
Conclusion: Evidence-based practice exercise programming may attenuate the prevalence of 
exercise training-induced ACR. Our findings provide important preliminary evidence needed for 
the vision of exercise prescription as a personalized form of preventative medicine to become 
a reality.
Keywords: evidence-based research, cardiovascular health, community-based research, 
metabolic health
Introduction
It is well accepted that regular exercise has positive effects on health outcomes related 
to cardiovascular morbidity and mortality.1 Emerging evidence suggests individual 
variability in exercise-induced changes in common cardiovascular disease (CVD) 
risk factors, with some individuals experiencing adverse responses (a response in 
an unfavorable direction) when exposed to regular exercise.2–4 With exercise being 
recognized as an effective treatment for many obesity-related conditions,3 understand-
ing factors associated with adverse responses is of growing importance. To date, few 
studies have evaluated adverse responses to exercise and results are conflicting.2–5 In a 
recent study2 that combined data from six exercise intervention studies, it was reported 
that adverse responses in individual cardiovascular and metabolic (cardiometabolic) 
risk factors ranged from 8% to 13% in sedentary adults undergoing 4 to 6 months of 
aerobic exercise training. Additionally, Yates et al5 reported 41% of participants ran-
domized to a pedometer-based intervention experienced at least one adverse response 
in cardiometabolic risk factors during the 12-month study. Interestingly, these authors 
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reported that the odds of an adverse response were reduced 
in those  participants who significantly increased physi-
cal activity during the study, suggesting that a progressive 
exercise prescription may be important in reducing adverse 
responses to exercise. In contrast, a study reported less than 
a 1% prevalence of adverse responses in heart failure patients 
attending cardiac rehabilitation; however, this study only 
investigated adverse responses in VO
2
 peak.4 Although these 
findings suggest that there may be individuals who experi-
ence adverse responses in cardiometabolic risk factors when 
engaging in exercise, it is important to identify whether those 
who experience adverse responses fall within the healthy 
range for a given risk factor. Whether the heterogeneity in 
response to exercise increases cardiometabolic risk in certain 
individuals is unknown but of growing importance. Further, 
whether an individualized, evidence-based exercise program 
results in a lower prevalence of adverse responders is cur-
rently unknown. Therefore, the purpose of this study was to 
determine the prevalence of individuals who experienced one 
or more adverse responses in cardiometabolic risk factors, fol-
lowing an evidence-based, individualized, community exercise 
program. We hypothesized that an individualized, evidence-
based exercise program would result in a low prevalence of 
adverse responses in cardiometabolic risk  factors. We also 
hypothesized that the majority of those who experience an 
adverse response for a given risk factor would not increase 
their risk stratification and would remain in the healthy range 
for that risk factor.
Methods
Study population
A cohort of 332 adults (190 women, 142 men; age range 
28–88 years) from a prior study6 in which components of 
metabolic syndrome (MetS) were measured before and after 
a 14-week evidenced-based community exercise program 
were analyzed for adverse cardiometabolic responses in the 
present study. All participants underwent a complete medical 
history and health assessment to determine if it was safe to 
engage in regular exercise. Participants were excluded from 
the study if they presented with a history of cardiovascular, 
pulmonary, or metabolic disease. This study was approved by 
the Institutional Review Board for the Protection of Human 
Subjects at the University of Wisconsin-Eau Claire.
assessment of cardiometabolic 
abnormalities
Body mass and height were measured using a medical beam 
balance (Cardinal Scale Manufacturing Co, Webb City, 
MO, USA). Body mass index was calculated as weight 
( kilograms) divided by height (meters) squared. Abdominal 
obesity was estimated by waist circumference measured at 
the smallest part of the abdomen, at the highest part of the 
iliac crest at the end of normal expiration. Auscultatory rest-
ing blood pressure was measured twice on at least two sepa-
rate occasions following 5 minutes of seated quiet rest using 
standard procedures. A small sample of blood was obtained 
from the index finger and analyzed for fasting plasma lipids, 
lipoproteins, and glucose concentrations under strict stan-
dardized operating procedures (Cholestech LDX System, 
Alere Inc., Waltham, MA, USA). Independent studies indi-
cate that the Cholestech system has excellent reproducibility 
with standard clinical laboratory measurement of plasma 
lipids and lipoproteins7,8 and meets the National Cholesterol 
Education Program Adult Treatment Panel (NCEP-ATP) III 
criteria for accuracy and  reproducibility.9 Conventional 
sub-maximal exercise tests (ie, Rockport walk protocol 
or the Astrand-Rhyming cycle ergometry  protocol) were 
administered using standardized procedures10 to estimate 
cardiorespiratory fitness. The sub-maximal tests selected 
for each participant were based on their training goals and 
whether they presented with musculoskeletal limitations that 
precluded the safe use of a particular test. Each participant 
completed the same sub-maximal exercise test at baseline 
and after the exercise program.
evidence-based community exercise 
programming
A complete description of the sample, study design, and exer-
cise training protocol has been described elsewhere.6 Briefly, 
using evidence from the STRRIDE study, each participant was 
provided an exercise prescription with an individualized weekly 
energy expenditure goal of 14–23 kcal ⋅ kg-1 ⋅ week-1.11–13 The 
weekly energy expenditure goal was used to calculate a 
minimum weekly exercise duration necessary to modify 
cardiovascular risk (corresponding to 40%–60% target VO
2
 
reserve) using the following calculation:
Minimum minutes of exercise per week  
 =  [14 kcal ⋅ kg-1 ⋅ week-1 × participant body mass]  
÷ [(40% target VO
2
 reserve work load  
× participant body mass) ÷ 1000×5 kcal ⋅ L O
2
-1] (1)
Exercise volume (minutes/week) was then divided by 
the target frequency goal for each participant to obtain daily 
exercise duration. Appropriate and safe individualized exer-
cise prescriptions were designed for each participant by an 
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 exercise physiologist and also based on differences in age, 
sex, and fitness. In general, exercise volume and exercise 
intensity were progressed according to published guidelines.10 
Each participant consulted with a team of exercise profession-
als and was assigned a University of Wisconsin-Eau Claire 
Department of Kinesiology senior student who served as 
their exercise trainer. The trainers worked directly under the 
supervision of qualified PhD-trained exercise physiologists. 
Exercise training consisted of brisk walking, water aerobics, 
stationary cycling or cross-training, and supervised strength 
training for at least 3 days per week between 5:30 am and 
8 am. Trainers coached participants during exercise sessions, 
provided motivational support, engaged in spotting, and cor-
rected exercise technique.
Definition of adverse cardiometabolic 
response to exercise
Two separate definitions of exercise-induced adverse car-
diometabolic response (ACR) to exercise were established. 
Our first ACR definition used threshold criteria similar to 
those published elsewhere.2 These included an exercise 
training-induced increase in systolic blood pressure (SBP) 
of $10 mmHg, increase in plasma triglycerides (TG) 
of .37.0 mg/dL ($0.42 mmol/L), or decrease in high-
density lipoprotein cholesterol (HDL-C) of .4.0 mg/dL 
($0.12 mmol/L). A second definition of ACR was ACR that 
resulted in a net gain of one MetS component (ACR-risk) 
as a consequence of the adverse response. For example, an 
exercise training-induced increase of 12 mmHg resulting 
in an SBP increase from 126 mmHg to 138 mmHg would 
transition an individual into the “positive” MetS component 
category for elevated blood pressure (ie, ACR-risk). The 
threshold criteria for MetS components were established 
according to NCEP-ATP III criteria.14,15 Framingham risk 
score, using the sex-specific algorithm for 10-year CVD risk, 
was calculated as previously described.16
Statistical analysis
All analyses were performed using Statistical Package for the 
Social Sciences, Version 19.0 (IBM Corporation, Armonk, 
NY, USA). All variables were initially checked for normality. 
Measures of centrality and spread are presented as frequency 
and mean ± standard deviation. Fisher’s exact chi-square 
(χ2) tests were used to analyze the point prevalence of ACR 
and ACR-risk in the total cohort between baseline and post-
program. Mean differences in 10-year CVD risk between 
baseline and post-program for ACR-risk were assessed using 
paired t-tests. Mean differences in change in VO
2
max and 
post-program relative energy expenditure between those 
participants who did not experience an ACR “no ACR-risk” 
and “ACR-risk” were assessed using independent t-tests. 
The level of statistical significance was set at P,0.05 for 
all analyses.
Results
All participants completed the 14-week exercise program 
without incident, although there was variability in the vol-
ume of exercise performed. The mean exercise intensity for 
the cohort was 42% VO
2
 reserve (range: 26%–76% VO
2
 
reserve).
Prevalence of acr
Evidence-based practice exercise programming favorably 
impacted the cardiometabolic profile of many participants. 
Changes in physical and physiological characteristics of the 
study population in response to the exercise program have 
been reported elsewhere in a prior publication.6 When exam-
ining the prevalence of specific MetS risk factor components 
using χ2 difference testing, there were significant differences 
(P,0.05) in all MetS risk factors components between base-
line and post-program. In fact, the percentage of participants 
with elevated waist circumference (49.7%), impaired fasting 
blood glucose (30.1%), low HDL-C (21.4%), elevated TG 
(20.2%), and elevated blood pressure (2.1%) was significantly 
(P,0.05) reduced post-program.
When examining the prevalence of ACR using χ2 differ-
ence testing, there were non-significant differences (P.0.05) 
between baseline and post-program. Overall prevalence 
of ACR was 4.9% (49/996). The breakdown of each individ-
ual ACR was 6.0% (20/332) for SBP, 3.6% (12/332) for TG, 
and 5.1% (17/332) for HDL-C. The prevalence of multiple 
ACR was 1.2% (4/332). The distribution of cardiometabolic 
responses for SBP, HDL-C, and TG to the evidence-based 
community exercise program are presented in Figure 1.
Prevalence of acr-risk
When examining the prevalence of ACR-risk using 
χ2 difference testing, there were non-significant differences 
(P.0.05) between baseline and post-program. The preva-
lence of ACR-risk for elevated TG (3.2%), impaired fasting 
blood glucose (2.7%), low HDL-C (2.2%), elevated waist 
circumference (1.3%), and elevated blood pressure (0.6%) 
was low. More men (n=15) compared to women (n=7) were 
ACR-risk. There was only a single individual with multiple 
ACR-risk. The breakdown of no ACR-risk and ACR-risk for 
each MetS component, along with training outcome  markers, 
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are  presented in Table 1. Independent t-tests showed no sig-
nificant differences (P.0.05) for energy expenditure and 
change in cardiorespiratory fitness between the “no-ACR 
risk” and “ACR-risk” cohorts.
Demographics, 10-year CVD risk scores at baseline and 
post-program, and change in cardiorespiratory fitness for 
each individual who presented with ACR-risk are shown 
in Table 2. Paired t-tests revealed no significant mean 
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Figure 1 Distribution of all cardiometabolic responses for systolic blood pressure 
(SBP), high-density lipoprotein cholesterol (hDl-c), and triglyceride to the 
evidence-based community exercise program.
Note: red color represents exercise training-induced acr.
Abbreviation: acr, exercise-induced adverse cardiometabolic response.
Table 1 Breakdown of no acr-risk and acr-risk for each MetS 
component and training outcome markers (energy expenditure 
and change in cardiorespiratory fitness) for each group
MetS  
component
Group (n) EE  
(kcal/kg/wk)
Change CR 
fitness (%)
elevated Wc no acr-risk (152) 
acr-risk (2)
18.2±6.3a
15.5±2.0
9.8±10.8
5.8±2.1
elevated BP no acr-risk (307) 17.2±5.8 10.5±12.1
acr-risk (2) 15.8±9.9 11.4±9.6
low hDl-c no acr-risk (228) 16.6±5.0 9.0±5.3
acr-risk (5) 10.2±11.5 8.0±9.0
elevated Tg no acr-risk (239) 17.1±5.8 10.3±11.5
acr-risk (8) 18.3±4.8 12.6±18.1
iFg no acr-risk (177) 
acr-risk (5)
17.0±6.6
16.4±2.2
10.1±10.3
7.9±4.5
Notes: aMean ± standard deviation. acr-risk: adverse cardiometabolic response 
who gained a metabolic syndrome component. no acr-risk: no adverse 
cardiometabolic response.
Abbreviations: acr, exercise-induced adverse cardiometabolic response; 
MetS, metabolic syndrome; ee, energy expenditure; cr, cardiorespiratory; 
Wc, waist circumference; BP, blood pressure; hDl-c, high-density lipoprotein 
cholesterol; Tg, triglycerides; iFg, impaired fasting blood glucose.
 differences (P.0.05) between baseline and post-program 
10-year CVD risk scores.
Discussion
The primary finding of the present study was that prevalence 
of ACR was low amongst participants within an evidence-
based, community exercise program. Indeed, the prevalence 
of ACR and ACR-risk ranged from 3.6% to 6.0% and 
0.6% to 3.2%, respectively. Moreover, our findings showed 
very few multiple exercise training-induced ACR (1.2%). 
These ACR figures are substantially lower than those reported 
previously in the literature2 which ranged from 10.3% to 
13.3%, and support the tremendous potential of evidence-
based exercise programming to enhance training efficacy and 
limit training unresponsiveness.
It is plausible that differences in prevalence of ACR 
between the present study and those reported elsewhere2 can 
be attributable to evidence-based practice. Evidence-based 
practice, as it pertains to exercise prescription, entails inte-
gration of the highest available level of research evidence, 
clinical exercise physiologist expertise, and patient/client 
needs.17,18 Randomized controlled trials address the first two 
aspects of evidence-based practice; however, patient/client 
needs are rarely considered as it compromises integrity of 
the research design. For example, participants in a study who 
are unable to complete the recommended weekly volume of 
exercise are not provided with the alternative of a reduced 
weekly goal. Similarly, if a participant finds the target exercise 
intensity less than desirable, it is not  permissible for intensity 
 
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015:8 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
77
adverse cardiometabolic responses to exercise
Table 2 Demographics, 10-year CVD risk scores at baseline and post-program, and change in cardiorespiratory fitness for each 
individual acr-risk
N Age  
(yrs)
Sex MetS 
component (s)
BL 10-yr 
CVD risk (%)
PP 10-yr 
CVD risk (%)
Change 
CR fitness (%)
1 55 Men elevated Wc 4 3 4.3
2 45 Men elevated Wc/BP* 3 3 7.3
3 62 Men elevated BP 10 9 18.3
4 52 Men elevated BP 2 2 4.6
5 79 Women elevated Tg 2 2 12.6
6 63 Women elevated Tg 2 2 -5.0
7 63 Men elevated Tg 11 13 20.8
8 48 Men elevated Tg 2 2 8.9
9 55 Men elevated Tg 6 4 22.2
10 58 Women elevated Tg 1 1 1.8
11 46 Men elevated Tg 4 4 13.6
12 65 Men elevated Tg 11 10 -9.1
13 51 Men low hDl-c 3 5 0.5
14 55 Men low hDl-c 9 8 20.6
15 63 Women low hDl-c 2 2 13.5
16 77 Men low hDl-c 16 15 0.3
17 57 Men low hDl-c 7 8 5.7
18 79 Men iFg 30 30 13.3
19 61 Women iFg 2 2 1.8
20 56 Women iFg 0 0 5.7
21 63 Women iFg 1 0 11.1
22 45 Men iFg 3 3 7.3
Mean 59.0 – – 6.0 5.8 8.2
SD 10.0 – – 6.8 6.8 8.3
Notes: *Denotes multiple acr-risk. acr-risk: adverse cardiometabolic response who gained a metabolic syndrome component.
Abbreviations: acr, exercise-induced adverse cardiometabolic response; MetS, metabolic syndrome; ee, energy expenditure; cr, cardiorespiratory; Wc, waist 
circumference; BP, blood pressure; hDl-c, high-density lipoprotein cholesterol; Tg, triglycerides; iFg, impaired fasting blood glucose; cVD, cardiovascular disease; yr, year; 
Bl, baseline; PP, post-program; SD, standard deviation.
to be titrated upward to meet individual  preferences. Yet in 
the clinical setting, it is paramount that exercise prescription 
design/implementation/progression includes input from the 
individual. Numerous factors, including differences in fitness, 
body weight, sex, and personal exercise preferences, all must 
be accounted for to improve the quality of the individual exer-
cise prescription to favorably modify cardiometabolic risk.
It is well established that considerable interindividual 
variability occurs in the positive physiological adaptations 
to exercise training.19 However, only more recently has the 
phenomenon of ACR been comprehensively explored,2 and 
presently no standardized definition for ACR exists in the 
literature. Classification and interpretation of an ACR may 
require a holistic view that integrates all exercise training 
outcomes. For example, in the present study an ACR rarely 
resulted in higher risk. In fact, 10-year CVD risk increased in 
only three individuals as highlighted in Table 2. This finding 
has practical implications suggesting that although some 
individuals may have adverse cardiometabolic responses to 
exercise training, this may not always result in increased risk 
and exercise may benefit these participants in different ways, 
such as improved cardiorespiratory fitness. Indeed, more than 
40% (9/22) of ACR-risk individuals concurrently increased 
cardiorespiratory fitness levels by 10% or more (see Table 2). 
Higher levels of cardiorespiratory fitness have been offered as 
an antidote toward other risk factors. Moreover, the literature 
suggests a 15% reduction in mortality for a 10% improvement 
in cardiorespiratory fitness.20 Taken together, it may be unin-
tentionally misleading to categorize someone as an “adverse 
responder to exercise” based on a single cardiometabolic 
factor when it is well known that regular exercise training 
confers a myriad of benefits. Clearly, the topic of adverse 
responders to exercise warrants much additional study.
There are a few experimental considerations regarding 
the present study. First, as with all retrospective studies, 
we cannot rule out the possibility that other factors (eg, 
dietary and sedentary behavior/sitting time) contributed to 
prevalence of ACR, irrespective of the community exercise 
program. Second, we applied criteria for ACR established 
elsewhere rather than based on a quantification of our own 
technical error measures. Had we done the latter our ACR 
prevalence data may have differed. Third, our sample was 
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a convenience sample of volunteers, which may limit the 
generalizability of the findings.
In conclusion, evidence-based practice exercise pro-
gramming may attenuate the prevalence of exercise-induced 
ACR in adults. Our findings provide important preliminary 
evidence needed for the vision of exercise prescription as 
a personalized form of preventative medicine to become a 
 reality. Indeed, for the “exercise is medicine” mantra to be 
fully realized, the same evidence-based practice approach 
widely applied in the medical community must too be 
embraced within the discipline of exercise science.
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